What is CVE-2026-1345?

CVE-2026-1345 is a high-severity vulnerability in Ibm Security Verify Access, classified under OS Command Injection. CVSS score: 7.3/10. Published 2026-04-01.

How severe is CVE-2026-1345?

High severity. CVSS v3 base score is 7.3 out of 10.

RCE in Ibm Security Verify Access

CVE-2026-1345

IBM Verify Identity Access Container 11.0 through 11.0.2 and IBM Security Verify Access Container 10.0 through 10.0.9.1 and IBM Verify Identity Access 11.0 through 11.0.2 and IBM Security Verify Access 10.0 through 10.0.9.1 could allow an…

Vulnerability class: Command Injection (OS Command Injection)

EPSS: 0.001 (18.9th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 7.3 (High). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L.

Affected products

Ibm Security Verify Access — versions 10.0
Ibm Security Verify Access Container — versions 10.0
Ibm Verify Identity Access — versions 11.0
Ibm Verify Identity Access Container — versions 11.0

Weakness classification (CWE)

CWE-78 — OS Command Injection

References

www.ibm.com/support/pages/node/7268253 (vendor-advisory, patch)

Frequently asked questions

What is CVE-2026-1345?: CVE-2026-1345 is a high-severity vulnerability in Ibm Security Verify Access, classified under OS Command Injection. CVSS score: 7.3/10. Published 2026-04-01.
How severe is CVE-2026-1345?: High severity. CVSS v3 base score is 7.3 out of 10.